Assenagon Asset Management S.A. Axsome Therapeutics, Inc. Transaction History
Assenagon Asset Management S.A.
- $54.1 Billion
- Q4 2024
A detailed history of Assenagon Asset Management S.A. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 3,701 shares of AXSM stock, worth $438,679. This represents 0.0% of its overall portfolio holdings.
Number of Shares
3,701
Previous 4,483
17.44%
Holding current value
$438,679
Previous $402,000
22.14%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding AXSM
# of Institutions
351Shares Held
35.7MCall Options Held
1.77MPut Options Held
1.16M-
Rtw Investments, LP New York, NY4.05MShares$480 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$463 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$391 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$174 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$165 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $5.08B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...